Rapid communicationmRNA distribution of the thalidomide binding protein cereblon in adult mouse brain
Research highlights
▶ All brain neurons express cereblon mRNA with various intensities. ▶ Glial expression of cereblon mRNA is limited. ▶ Cereblon mRNA levels are the highest in hippocampal pyramidal cells and cerebellar Purkinje cells. ▶ Cereblon mRNA is enriched in serotonergic and noradrenergic neurons as well.
Section snippets
Acknowledgements
This work was supported by the Basic Scientific Research (B), the Health and Labor Sciences Research Grants, a grant for Promotion of Niigata University Research Projects, and Core Research for Evolutional Science and Technology from the JST Corporation.
References (22)
- et al.
In situ hybridization reveals developmental regulation of ErbB1–4 mRNA expression in mouse midbrain: implication of ErbB receptors for dopaminergic neurons
Neuroscience
(2009) - et al.
Cereblon is expressed in the retina and binds to voltage-gated chloride channels
FEBS Lett.
(2009) - et al.
Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism
Int. J. Dev. Neurosci.
(2005) - et al.
Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat
Neurosci. Res.
(2010) - et al.
Whole blood serotonin in autistic and normal subjects
J. Child Psychol. Psychiatry
(1987) - et al.
The hyperserotonemia of autism
Ann. N. Y. Acad. Sci.
(1990) - et al.
Molecular architecture and assembly of the DDB1–CUL4A ubiquitin ligase machinery
Nature
(2006) Role of altered brain serotonin mechanisms in autism
Mol. Psychiatry
(2002)- et al.
PET: mapping of serotonin synthesis
Adv. Neurol.
(2000) - et al.
Altered serotonin synthesis in the dentatothalamocortical pathway in autistic boys
Ann. Neurol.
(1997)
Clinical pharmacology of thalidomide
Eur. J. Clin. Pharmacol.
Cited by (18)
The Ubiquitination-Dependent and -Independent Functions of Cereblon in Cancer and Neurological Diseases
2022, Journal of Molecular BiologyCitation Excerpt :The human protein cereblon (CRBN, UniProt accession #: Q96SW2) contains 442 amino acids and consists of a Lon-N-terminal domain without the ATP-binding and catalytic domains at its N terminus, and an IMiD-binding motif at its C terminus (Figure 1(A)).19 It is highly expressed in cerebellum and plays important roles in cerebral development.20,21 Hence, it is named as cereblon.
Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions
2022, Current Research in Pharmacology and Drug DiscoveryExploiting ubiquitin ligase cereblon as a target for small-molecule compounds in medicine and chemical biology
2021, Cell Chemical BiologyCitation Excerpt :As mentioned above, mutations of human CRBN are associated with intellectual disability, implying that CRBN plays a role in brain function. Rodent Crbn is widely expressed in post-mitotic neurons in the adult brain, including the hippocampus, cerebellum, and cortex (Aizawa et al., 2011). In 2012, germ line Crbn-deficient mice and forebrain-specific Crbn-deficient mice were established (Rajadhyaksha et al., 2012).
Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation
2019, iScienceCitation Excerpt :DDB1, one of the subunits of CRL4CRBN, is required for cell proliferation through the p53-dependent pathway in the developing brain (Cang et al., 2006; Hu et al., 2015). Coincidentally, CRBN was originally reported as a gene responsible for autosomal recessive, non-syndromic mental retardation in humans (Higgins et al., 2004) and is highly expressed in the vertebrate brain (Higgins et al., 2010; Aizawa et al., 2011). In addition, it has been reported that CRBN also regulates the expression of functional large-conductance, Ca2+- and voltage-activated K+ (BK) channels, which are involved in neuronal excitability and epileptogenesis (Jo et al., 2005; Liu et al., 2014).
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
2018, Blood AdvancesCitation Excerpt :We and others reported single-agent activity of lenalidomide in refractory secondary CNS diffuse large B-cell lymphoma (DLBCL) as well as mantle cell lymphoma involving the CNS.18,19 Given reports of neurotoxicity associated with lenalidomide and other immunomodulatory drugs in the setting of myeloma and other lymphoid malignancies,20,21 that the direct binding protein and mediator of cellular activity of lenalidomide, cereblon, is highly expressed in neurons in the brain,22,23 and that it is well-established that CNS lymphoma patients are at high risk for neurocognitive deficits and neurotoxicity, we designed a phase 1 investigation to determine a safe, maximum tolerated dose (MTD) of lenalidomide for this patient population. The rationale for this approach is also supported by the fact that CNS lymphoma patients often have a poor performance status and are particularly vulnerable because of immune suppression.
New hopes in relapsed refractory primary central nervous system lymphoma
2023, Current Opinion in Oncology